DISEASE ADVANCES

Long-term diabetes management requires continuous blood glucose monitoring to detect abnormalities early and intervene in time. However, conventional fingertip blood sampling is both painful and inconvenient, while most continuous glucose monitoring (CGM) products currently available on the market rely on biological enzymes—requiring regular replacement, incurring higher costs and demanding stringent storage conditions.

Multiple sclerosis (MS) is the most common chronic autoimmune disease of the central nervous system. An early and accurate diagnosis is crucial for improving the effectiveness of treatment and reducing nerve damage.

What if certain signs of the disease were to manifest subtly during sleep, long before the first memory problems appear? This is the line of inquiry being explored by a team of researchers at ULiège.